BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 19549592)

  • 21. Nongenomic steroid actions: completing the puzzle. Aldosterone as an example.
    Schmidt BM; Christ M; Falkenstein E; Wehling M
    Exp Clin Endocrinol Diabetes; 1998; 106(6):441-5. PubMed ID: 10079021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EF domains are sufficient for nongenomic mineralocorticoid receptor actions.
    Grossmann C; Freudinger R; Mildenberger S; Husse B; Gekle M
    J Biol Chem; 2008 Mar; 283(11):7109-16. PubMed ID: 18184651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.
    Young MJ
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):174-80. PubMed ID: 18277151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrinology of aldosterone].
    Ronconi V; Giacchetti G; Boscaro M
    Ital Heart J; 2005 May; 6 Suppl 1():5S-15S. PubMed ID: 15945295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone and end-organ damage.
    Marney AM; Brown NJ
    Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid actions of aldosterone in vascular health and disease--friend or foe?
    Skøtt O; Uhrenholt TR; Schjerning J; Hansen PB; Rasmussen LE; Jensen BL
    Pharmacol Ther; 2006 Aug; 111(2):495-507. PubMed ID: 16413609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention.
    Kolodziejczyk P; Gromotowicz-Poplawska A; Aleksiejczuk M; Chabielska E; Tutka P; Miltyk W
    Curr Drug Targets; 2018; 19(16):1968-1979. PubMed ID: 29577853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling.
    Grossmann C; Ruhs S; Langenbruch L; Mildenberger S; Strätz N; Schumann K; Gekle M
    Chem Biol; 2012 Jun; 19(6):742-51. PubMed ID: 22726688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone.
    Lemarié CA; Paradis P; Schiffrin EL
    J Mol Med (Berl); 2008 Jun; 86(6):673-8. PubMed ID: 18368382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aldosterone: the mechanisms of molecular action].
    Logvinenko NS
    Ross Fiziol Zh Im I M Sechenova; 2007 Jul; 93(7):746-61. PubMed ID: 17912848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New ideas about aldosterone signaling in epithelia.
    Stockand JD
    Am J Physiol Renal Physiol; 2002 Apr; 282(4):F559-76. PubMed ID: 11880316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldosterone-induced signalling and cation transport in the distal nephron.
    Thomas W; McEneaney V; Harvey BJ
    Steroids; 2008 Oct; 73(9-10):979-84. PubMed ID: 18308353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms underlying rapid aldosterone effects in the kidney.
    Thomas W; Harvey BJ
    Annu Rev Physiol; 2011; 73():335-57. PubMed ID: 20809792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Genomic Effects of Aldosterone.
    Mihailidou AS; Tzakos AG; Ashton AW
    Vitam Horm; 2019; 109():133-149. PubMed ID: 30678853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mineralocorticoid signaling pathway throughout development: expression, regulation and pathophysiological implications.
    Martinerie L; Munier M; Le Menuet D; Meduri G; Viengchareun S; Lombès M
    Biochimie; 2013 Feb; 95(2):148-57. PubMed ID: 23026756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving research in nongenomic actions of aldosterone.
    Williams JS
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):198-203. PubMed ID: 23519092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of corticosteroid-regulated genes in cardiomyocytes by serial analysis of gene expression.
    Muller O; Pradervand S; Berger S; Centeno G; Milet A; Nicod P; Pedrazzini T; Tronche F; Schütz G; Chien K; Rossier BC; Firsov D
    Genomics; 2007 Mar; 89(3):370-7. PubMed ID: 17174066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nongenomic actions of aldosterone.
    Funder JW
    Endocr Rev; 2005 May; 26(3):313-21. PubMed ID: 15814845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of epithelial ion transport by aldosterone through changes in gene expression.
    Bhargava A; Wang J; Pearce D
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):189-96. PubMed ID: 15134817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrarenal effects of aldosterone.
    Nguyen Dinh Cat A; Jaisser F
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):147-56. PubMed ID: 22240440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.